Colchicine Tablet
Product Images NDC 16714-039

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 16714-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3a3424dd Bec5 46b5 B7ad 4c4930e7c9a4 01)

A formula for calculating creatinine clearance (Clcr) based on age, weight, serum creatinine, with an adjustment factor for female patients. The formula includes variables for age in years, weight in kilograms, and serum creatinine in mg/dL, adjusted by 0.85 for females.*

FDA Label Image

Image (3a3424dd Bec5 46b5 B7ad 4c4930e7c9a4 02)

Chemical structure of the active ingredient colchicine, showing its molecular arrangement with labeled rings and functional groups including methoxy and acetyl moieties. The diagram illustrates the arrangement of carbon, oxygen, nitrogen, and hydrogen atoms in colchicine.*

FDA Label Image

Image (3a3424dd Bec5 46b5 B7ad 4c4930e7c9a4 03)

A line graph comparing the percentage of patients improved at various improvement percentages for three groups: Colchicine low-dose (1.8 mg), Colchicine high-dose (4.8 mg), and placebo. The x-axis shows percentage improvement from >0 to 100%, and the y-axis shows the percentage of patients improved from 0% to 100%. The lines depict higher patient improvement rates with colchicine doses compared to placebo across improvement levels.*

FDA Label Image

Image (3a3424dd Bec5 46b5 B7ad 4c4930e7c9a4 04)

Colchicine Tablets, USP 0.6 mg oral tablets label from Northstar Rx LLC. The label indicates 30 tablets per package with pharmacy dispensing instructions. It includes storage information, child resistance warning, and manufacturer details: Cadila Healthcare Ltd., India. The NDC is 16714-039-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.